Clinical Trial Update: PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

View source ↗

Summary

The clinical trial update describes using PET-CT imaging to monitor pancreatic beta-cell loss in Type 1 diabetes mellitus. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of California, Irvine | Conditions: Type1 Diabetes Mellitus | Status: COMPLETED